Berger Carolina, Jensen Michael C, Lansdorp Peter M, Gough Mike, Elliott Carole, Riddell Stanley R
Fred Hutchinson Cancer Research Center, Seattle, Washington 98109-1024, USA.
J Clin Invest. 2008 Jan;118(1):294-305. doi: 10.1172/JCI32103.
The adoptive transfer of antigen-specific T cells that have been expanded ex vivo is being actively pursued to treat infections and malignancy in humans. The T cell populations that are available for adoptive immunotherapy include both effector memory and central memory cells, and these differ in phenotype, function, and homing. The efficacy of adoptive immunotherapy requires that transferred T cells persist in vivo, but identifying T cells that can reproducibly survive in vivo after they have been numerically expanded by in vitro culture has proven difficult. Here we show that in macaques, antigen-specific CD8(+) T cell clones derived from central memory T cells, but not effector memory T cells, persisted long-term in vivo, reacquired phenotypic and functional properties of memory T cells, and occupied memory T cell niches. These results demonstrate that clonally derived CD8+ T cells isolated from central memory T cells are distinct from those derived from effector memory T cells and retain an intrinsic capacity that enables them to survive after adoptive transfer and revert to the memory cell pool. These results could have significant implications for the selection of T cells to expand or to engineer for adoptive immunotherapy of human infections or malignancy.
体外扩增的抗原特异性T细胞的过继性转移正在被积极探索用于治疗人类感染和恶性肿瘤。可用于过继性免疫治疗的T细胞群体包括效应记忆细胞和中枢记忆细胞,它们在表型、功能和归巢方面存在差异。过继性免疫治疗的疗效要求转移的T细胞在体内持续存在,但要鉴定出在体外培养大量扩增后能在体内持续存活的T细胞却很困难。在此我们表明,在猕猴中,源自中枢记忆T细胞而非效应记忆T细胞的抗原特异性CD8(+) T细胞克隆能在体内长期存活,重新获得记忆T细胞的表型和功能特性,并占据记忆T细胞龛位。这些结果表明,从中枢记忆T细胞分离出的克隆性CD8+ T细胞不同于从效应记忆T细胞衍生的细胞,并且保留了一种内在能力,使其在过继性转移后能够存活并回归记忆细胞池。这些结果可能对选择用于人类感染或恶性肿瘤过继性免疫治疗的T细胞进行扩增或改造具有重要意义。